Reuters logo
BRIEF-Sanofi receives CHMP recommendation for approval of insulin lispro biosimilar
May 19, 2017 / 11:18 AM / 4 months ago

BRIEF-Sanofi receives CHMP recommendation for approval of insulin lispro biosimilar

May 19 (Reuters) - SANOFI SA

* REG-SANOFI RECEIVES CHMP RECOMMENDATION FOR APPROVAL OF INSULIN LISPRO BIOSIMILAR

* POSITIVE OPINION BASED ON A CLINICAL DEVELOPMENT PROGRAM INVOLVING OVER 1,000 PEOPLE WITH TYPE 1 OR TYPE 2 DIABETES

* EUROPEAN COMMISSION IS EXPECTED TO MAKE A FINAL DECISION ON MARKETING AUTHORIZATION FOR INSULIN LISPRO SANOFI(® )IN COMING MONTHS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below